[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.238.190.122. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link?  Diabetes Care. 2000;23(10):1556-156211023152PubMedGoogle ScholarCrossref
2.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis.  Diabetes Care. 2001;24(6):1069-107811375373PubMedGoogle ScholarCrossref
3.
Saydah SH, Brancati FL, Golden SH, Fradkin J, Harris MI. Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample.  Diabetes Metab Res Rev. 2003;19(3):202-20812789653PubMedGoogle ScholarCrossref
4.
Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes: a prospective population-based study.  Diabetes Care. 1996;19(10):1097-11028886555PubMedGoogle ScholarCrossref
5.
Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men.  Diabetes Care. 1999;22(7):1071-107610388970PubMedGoogle ScholarCrossref
6.
Carnethon MR, Kinder LS, Fair JM, Stafford RS, Fortmann SP. Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic follow-up study, 1971-1992.  Am J Epidemiol. 2003;158(5):416-42312936896PubMedGoogle ScholarCrossref
7.
Arroyo C, Hu FB, Ryan LM,  et al.  Depressive symptoms and risk of type 2 diabetes in women.  Diabetes Care. 2004;27(1):129-13314693978PubMedGoogle ScholarCrossref
8.
Golden SH, Williams JE, Ford DE,  et al.  Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study.  Diabetes Care. 2004;27(2):429-43514747224PubMedGoogle ScholarCrossref
9.
Carnethon MR, Biggs ML, Barzilay JI,  et al.  Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study.  Arch Intern Med. 2007;167(8):802-80717452543PubMedGoogle ScholarCrossref
10.
Everson-Rose SA, Meyer PM, Powell LH,  et al.  Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife.  Diabetes Care. 2004;27(12):2856-286215562197PubMedGoogle ScholarCrossref
11.
Palinkas LA, Lee PP, Barrett-Connor E. A prospective study of type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study.  Diabet Med. 2004;21(11):1185-119115498084PubMedGoogle ScholarCrossref
12.
Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study.  J Psychosom Res. 2007;62(1):31-3817188118PubMedGoogle ScholarCrossref
13.
Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus.  Curr Diabetes Rev. 2007;3(4):252-25918220683PubMedGoogle ScholarCrossref
14.
Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression.  Am J Psychiatry. 1988;145(3):325-3302894176PubMedGoogle Scholar
15.
Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL. High plasma norepinephrine levels in patients with major affective disorder.  Am J Psychiatry. 1982;139(10):1315-13186289682PubMedGoogle Scholar
16.
Roy A, Pickar D, De Jong J, Karoum F, Linnoila M. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine: relationship to hypothalamic-pituitary-adrenal axis function in depression.  Arch Gen Psychiatry. 1988;45(9):849-8573415426PubMedGoogle ScholarCrossref
17.
Maes M, Vandewoude M, Schotte C, Martin M, Blockx P. Positive relationship between the catecholaminergic turnover and the DST results in depression.  Psychol Med. 1990;20(3):493-4992173010PubMedGoogle ScholarCrossref
18.
Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality.  J Psychosom Res. 2002;53(4):873-87612377296PubMedGoogle ScholarCrossref
19.
Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey.  Arch Intern Med. 2004;164(9):1010-101415136311PubMedGoogle ScholarCrossref
20.
Golden SH, Lee HB, Schreiner PJ,  et al.  Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis.  Psychosom Med. 2007;69(6):529-53617636146PubMedGoogle ScholarCrossref
21.
de Jonge P, Roy JF, Saz P, Marcos G, Lobo A. Prevalent and incident depression in community-dwelling elderly persons with diabetes mellitus: results from the ZARADEMP project.  Diabetologia. 2006;49(11):2627-263317019601PubMedGoogle ScholarCrossref
22.
Maraldi C, Volpato S, Penninx BW,  et al.  Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study.  Arch Intern Med. 2007;167(11):1137-114417563021PubMedGoogle ScholarCrossref
23.
Polsky D, Doshi JA, Marcus S,  et al.  Long-term risk for depressive symptoms after a medical diagnosis.  Arch Intern Med. 2005;165(11):1260-126615956005PubMedGoogle ScholarCrossref
24.
Brown LC, Majumdar SR, Newman SC, Johnson JA. Type 2 diabetes does not increase risk of depression.  CMAJ. 2006;175(1):42-4616818907PubMedGoogle ScholarCrossref
25.
Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Vascular risk factors and incident late-life depression in a Korean population.  Br J Psychiatry. 2006;189:26-3016816302PubMedGoogle ScholarCrossref
26.
Lawlor DA, Hart CL, Hole DJ, Gunnell D, Davey SG. Body mass index in middle life and future risk of hospital admission for psychoses or depression: findings from the Renfrew/Paisley study.  Psychol Med. 2007;37(8):1151-116117407616PubMedGoogle ScholarCrossref
27.
Lawlor DA, Smith GD, Ebrahim S. Association of insulin resistance with depression: cross sectional findings from the British Women's Heart and Health Study.  BMJ. 2003;327(7428):1383-138414670883PubMedGoogle ScholarCrossref
28.
Golomb BA, Tenkanen L, Alikoski T,  et al.  Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screenees.  J Clin Epidemiol. 2002;55(8):767-77312384190PubMedGoogle ScholarCrossref
29.
Bild DE, Bluemke DA, Burke GL,  et al.  Multi-ethnic study of atherosclerosis: objectives and design.  Am J Epidemiol. 2002;156(9):871-88112397006PubMedGoogle ScholarCrossref
30.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population.  Appl Psychol Meas. 1977;1:385-401Google ScholarCrossref
31.
Radloff LS, Locke BZ. Center for Epidemiologic Studies Depression Scale (CES-D). In: Rush AJ, ed. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000:523-526
32.
Beekman AT, Deeg DJ, van Limbeek J, Braam AW, DeVries MA, VanTilburg W. Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older stujects in the Netherlands.  Psychol Med. 1997;27(1):231-2359122304PubMedGoogle ScholarCrossref
33.
Golding JM, Burnam MA. Immigration, stress, and depressive symptoms in a Mexican-American community.  J Nerv Ment Dis. 1990;178(3):161-1712307968PubMedGoogle ScholarCrossref
34.
Roberts RE. Reliability of the CES-D Scale in different ethnic contexts.  Psychiatry Res. 1980;2(2):125-1346932058PubMedGoogle ScholarCrossref
35.
American Diabetes Association.  Diagnosis and classification of diabetes mellitus.  Diabetes Care. 2006;29:(suppl 1)  S43-S4816373932PubMedGoogle Scholar
36.
Chobanian AV, Bakris GL, Black HR,  et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.  JAMA. 2003;289(19):2560-257212748199PubMedGoogle ScholarCrossref
37.
 Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).  JAMA. 1993;269(23):3015-30238501844PubMedGoogle ScholarCrossref
38.
Detrano R, Guerci AD, Carr JJ,  et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.  N Engl J Med. 2008;358(13):1336-134518367736PubMedGoogle ScholarCrossref
39.
Mayer-Davis EJ, Vitolins MZ, Carmichael SL,  et al.  Validity and reproducibility of a food frequency interview in a multi-cultural epidemiology study.  Ann Epidemiol. 1999;9(5):314-32410976858PubMedGoogle ScholarCrossref
40.
Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records.  J Clin Epidemiol. 1990;43(12):1327-13352254769PubMedGoogle ScholarCrossref
41.
Ainsworth BE, Irwin ML, Addy CL, Whitt MC, Stolarczyk LM. Moderate physical activity patterns of minority women: the Cross-Cultural Activity Participation Study.  J Womens Health Gend Based Med. 1999;8(6):805-81310495261PubMedGoogle ScholarCrossref
42.
American Diabetes Association.  Standars of medical care in diabetes—2006.  Diabetes Care. 2006;29:(suppl 1)  S4-S4216373931PubMedGoogle Scholar
43.
Marcus MD, Wing RR, Guare J, Blair EH, Jawad A. Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients.  Diabetes Care. 1992;15(2):253-2551547681PubMedGoogle ScholarCrossref
44.
Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment.  Biol Psychiatry. 2003;54(3):317-32912893107PubMedGoogle ScholarCrossref
45.
Black PH. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X.  Brain Behav Immun. 2003;17(5):350-36412946657PubMedGoogle ScholarCrossref
46.
Duncan BB, Schmidt MI, Pankow JS,  et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.  Diabetes. 2003;52(7):1799-180512829649PubMedGoogle ScholarCrossref
47.
Fava M. Weight gain and antidepressants.  J Clin Psychiatry. 2000;61:(suppl 11)  37-4110926053PubMedGoogle Scholar
48.
Sachs GS, Guille C. Weight gain associated with use of psychotropic medications.  J Clin Psychiatry. 1999;60:(suppl 21)  16-1910548137PubMedGoogle ScholarCrossref
49.
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis.  Psychosom Med. 2001;63(4):619-63011485116PubMedGoogle Scholar
50.
Miyaoka Y, Miyaoka H, Motomiya T, Kitamura S, Asai M. Impact of sociodemographic and diabetes-related characteristics on depressive state among non-insulin-dependent diabetic patients.  Psychiatry Clin Neurosci. 1997;51(4):203-2069316164PubMedGoogle ScholarCrossref
51.
Cohen ST, Welch G, Jacobson AM, de Groot M, Samson J. The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus.  Psychosomatics. 1997;38(2):98-1089063039PubMedGoogle ScholarCrossref
52.
Viinamäki H, Niskanen L, Uusitupa M. Mental well-being in people with non-insulin-dependent diabetes.  Acta Psychiatr Scand. 1995;92(5):392-3978619345PubMedGoogle ScholarCrossref
53.
Geringer ES, Perlmuter LC, Stern TA, Nathan DM. Depression and diabetic neuropathy: a complex relationship.  J Geriatr Psychiatry Neurol. 1988;1(1):11-153252874PubMedGoogle ScholarCrossref
54.
Black SA. Increased health burden associated with comorbid depression in older diabetic Mexican Americans: results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey.  Diabetes Care. 1999;22(1):56-6410333904PubMedGoogle ScholarCrossref
55.
Winocour PH, Main CJ, Medlicott G, Anderson DC. A psychometric evaluation of adult patients with type 1 (insulin-dependent) diabetes mellitus: prevalence of psychologicl dysfunction and relationship to demographic variables, metabolic control and complications.  Diabetes Res. 1990;14(4):171-1762132190PubMedGoogle Scholar
56.
Padgett DK. Sociodemographic and disease-related correlates of depressive morbidity among diabetic patients in Zagreb, Croatia.  J Nerv Ment Dis. 1993;181(2):123-1298426169PubMedGoogle ScholarCrossref
57.
Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.  Arch Intern Med. 2000;160(21):3278-328511088090PubMedGoogle ScholarCrossref
58.
Lloyd CE, Matthews KA, Wing RR, Orchard TJ. Psychosocial factors and complications of IDDM: the Pittsburgh Epidemiology of Diabetes Complications Study, VIII.  Diabetes Care. 1992;15(2):166-1721547672PubMedGoogle ScholarCrossref
59.
Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults.  Diabetes Care. 1997;20(4):585-5909096984PubMedGoogle ScholarCrossref
60.
Leedom L, Feldman M, Procci W, Zeidler A. Symptoms of sexual dysfunction and depression in diabetic women.  J Diabet Complications. 1991;5(1):38-411830317PubMedGoogle ScholarCrossref
61.
Robinson N, Fuller JH, Edmeades SP. Depression and diabetes.  Diabet Med. 1988;5(3):268-2742967150PubMedGoogle ScholarCrossref
62.
Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA. Contributors to depression in Latino and European-American patients with type 2 diabetes.  Diabetes Care. 2001;24(10):1751-175711574437PubMedGoogle ScholarCrossref
63.
Hänninen JA, Takala JK, Keinänen-Kiukaanniemi SM. Depression in subjects with type 2 diabetes: predictive factors and relation to quality of life.  Diabetes Care. 1999;22(6):997-99810372255PubMedGoogle ScholarCrossref
64.
Popkin MK, Callies AL, Lentz RD, Colon EA, Sutherland DE. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus.  Arch Gen Psychiatry. 1988;45(1):64-683257379PubMedGoogle ScholarCrossref
65.
Naliboff BD, Rosenthal M. Effects of age on complications in adult onset diabetes.  J Am Geriatr Soc. 1989;37(9):838-8422788181PubMedGoogle Scholar
66.
Karlson B, Agardh CD. Burden of illness, metabolic control, and complications in relation to depressive symptoms in IDDM patients.  Diabet Med. 1997;14(12):1066-10729455935PubMedGoogle ScholarCrossref
67.
Lawlor DA, Ben Shlomo Y, Ebrahim S,  et al.  Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly prospective cohort study.  BMJ. 2005;330(7493):705-70615684022PubMedGoogle ScholarCrossref
68.
McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. New York, NY: Oxford University Press; 1996
69.
Murphy JM. Symptom Scales and Diagnostic Schedules. In: Tsuang MT, Tohen M, eds. Textbook in Psychiatry Epidemiology. New York, NY: John Wiley & Sons Inc; 2002:273-332
70.
Rubin RR, Knowler WC, Ma Y,  et al.  Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants.  Diabetes Care. 2005;28(4):830-83715793181PubMedGoogle ScholarCrossref
Original Contribution
June 18, 2008

Examining a Bidirectional Association Between Depressive Symptoms and Diabetes

Author Affiliations

Author Affiliations: Departments of Medicine (Drs Golden and Lazo), Epidemiology (Drs Golden and Lazo), and Psychiatry (Drs Lee and Lyketsos), Johns Hopkins University, Baltimore, Maryland; Department of Preventive Medicine, Northwestern University, Chicago, Illinois (Dr Carnethon); Department of Epidemiology and Prevention, Wake Forest University, Winston-Salem, North Carolina (Dr Bertoni); Division of Epidemiology and Community Health, University of Minnesota, St Paul-Minneapolis (Dr Schreiner); and Department of Epidemiology, University of Michigan, Ann Arbor (Dr Diez Roux).

JAMA. 2008;299(23):2751-2759. doi:10.1001/jama.299.23.2751
Abstract

Context Depressive symptoms are associated with development of type 2 diabetes, but it is unclear whether type 2 diabetes is a risk factor for elevated depressive symptoms.

Objective To examine the bidirectional association between depressive symptoms and type 2 diabetes.

Design, Setting, and Participants Multi-Ethnic Study of Atherosclerosis, a longitudinal, ethnically diverse cohort study of US men and women aged 45 to 84 years enrolled in 2000-2002 and followed up until 2004-2005.

Main Outcome Measures Elevated depressive symptoms defined by Center for Epidemiologic Studies Depression Scale (CES-D) score of 16 or higher, use of antidepressant medications, or both. The CES-D score was also modeled continuously. Participants were categorized as normal fasting glucose (<100 mg/dL), impaired fasting glucose (100-125 mg/dL), or type 2 diabetes (≥126 mg/dL or receiving treatment). Analysis 1 included 5201 participants without type 2 diabetes at baseline and estimated the relative hazard of incident type 2 diabetes over 3.2 years for those with and without depressive symptoms. Analysis 2 included 4847 participants without depressive symptoms at baseline and calculated the relative odds of developing depressive symptoms over 3.1 years for those with and without type 2 diabetes.

Results In analysis 1, the incidence rate of type 2 diabetes was 22.0 and 16.6 per 1000 person-years for those with and without elevated depressive symptoms, respectively. The risk of incident type 2 diabetes was 1.10 times higher for each 5-unit increment in CES-D score (95% confidence interval [CI], 1.02-1.19) after adjustment for demographic factors and body mass index. This association persisted following adjustment for metabolic, inflammatory, socioeconomic, or lifestyle factors, although it was no longer statistically significant following adjustment for the latter (relative hazard, 1.08; 95% CI, 0.99-1.19). In analysis 2, the incidence rates of elevated depressive symptoms per 1000-person years were 36.8 for participants with normal fasting glucose; 27.9 for impaired fasting glucose; 31.2 for untreated type 2 diabetes, and 61.9 for treated type 2 diabetes. Compared with normal fasting glucose, the demographic–adjusted odds ratios of developing elevated depressive symptoms were 0.79 (95% CI, 0.63-0.99) for impaired fasting glucose, 0.75 (95% CI, 0.44-1.27) for untreated type 2 diabetes, and 1.54 (95% CI, 1.13-2.09) for treated type 2 diabetes. None of these associations with incident depressive symptoms were materially altered with adjustment for body mass index, socioeconomic and lifestyle factors, and comorbidities. Findings in both analyses were comparable across ethnic groups.

Conclusions A modest association of baseline depressive symptoms with incident type 2 diabetes existed that was partially explained by lifestyle factors. Impaired fasting glucose and untreated type 2 diabetes were inversely associated with incident depressive symptoms, whereas treated type 2 diabetes showed a positive association with depressive symptoms. These associations were not substantively affected by adjustment for potential confounding or mediating factors.

×